Table 1.
Study Participant Characteristics at Enrollment
| Variables | Total (n = 140) | Cohort, median (IQR) | Chi‐square d‐test p-value | |
|---|---|---|---|---|
| ASPM low (n = 70) | ASPM high (n = 70) | |||
| Age, (years) n (%) | 0.488 | |||
| ≤60 | 85 (61) | 40 (57) | 45 (64) | |
| >60 | 55 (39) | 30 (43) | 25 (36) | |
| Gender, n (%) | 0.037 | |||
| male | 87 (62) | 37 (53) | 50 (71) | |
| femal | 53 (38) | 33 (47) | 20 (29) | |
| Tumor size (cm), n (%) | 0.735 | |||
| ≤4 | 102 (73) | 50 (71) | 52 (73) | |
| >4 | 38 (27) | 20 (29) | 18 (27) | |
| Histological subtypes, n (%) | 1 | |||
| clear cell carcinoma | 121 (86) | 60 (86) | 61 (87) | |
| others | 19 (14) | 10 (14) | 9 (13) | |
| Histological grade, n (%) | <0.01 | |||
| I-II | 110 (79) | 65 (93) | 45 (65) | |
| III-IV | 30 (21) | 5 (7) | 25 (35) | |
| TNM staging, n (%) | <0.01 | |||
| I | 105 (75) | 63 (90) | 42 (60) | |
| II-IV | 35 (25) | 7 (10) | 28 (40) | |